Office of Technology Commercialization

Partners in Innovation: Advancing Georgetown’s breakthroughs for a brighter tomorrow
At Georgetown’s Office of Technology Commercialization, we are driven by a passionate commitment to transforming innovations into impactful solutions.
We are dedicated to propelling GU’s pioneering breakthroughs forward through strategic partnerships and creating new ventures. We are dedicated to bridging the gap between research excellence and real-world application, fostering an environment where entrepreneurship thrives, and ensuring our entire community benefits.
As your partners in innovation and research translation, we engage continuously with knowledgeable and accessible staff, ensuring your ideas make a meaningful impact on society. Welcome to a world of possibilities at the intersection of academia and entrepreneurship!

FY19-23 Commercialization Metrics

$3 MMReveueOngoing growth in tech transfer revenue.
81Issued patents (world-wide)Global patents surge, driving innovation.
$1MMGap fundings awardedInnovative projects funded, bridging gaps.


News

Featured News

NIH SBIR/STTR Programs Funding Opportunities Learning Session

Georgetown University and George Washington University faculty and staff learned about the National Cancer Institute’s Small Business Innovation Research Development Center Programs. Georgetown’s…

February 7, 2024

Featured News

Celebrating Dr. Christian Wolf’s selection to the National Academy of Inventors

We are thrilled to share that our esteemed faculty, Dr. Christian Wolf, Ph.D., has been selected for induction as a Fellow in the National Academy of Inventors (NAI).The 2023 NAI Fellows Selection…

December 12, 2023

Featured News

DC-Maryland-Virginia Regional Tech Transfer Office Forum

Georgetown’s Office of Technology Commercialization staff attended the Winter 2023 DC-Maryland-Virginia (DMV) Regional Tech Transfer Office (TTO) Forum on November 30, 2023. The event brought…

December 1, 2023


Technology Spotlight

Advancing Cancer Therapy: Innovative Predictive Model for CAR-T Treatment Efficacy

Georgetown researchers have developed a cutting-edge method involving tumor biopsies and zebrafish xenografts to assess the potential response to CAR-T cell therapy before treatment initiation.

Learn More

Advancing NeonatalCare: Fibractant – A Synthetic Lung Surfactant for Premature Infants

Georgetown University has pioneered a remarkable synthetic lung surfactant known as “Fibractant.” Composed of silk fibroin and DPPC lipids, this innovation holds high potential in the realm of respiratory care, offering a sustainable alternative to conventional methods.

Learn More

Antimicrobial Transdermal Delivery: Reducing Infection Risks with Minimally Invasive Technology

Georgetown University researchers have developed a groundbreaking technology that addresses the critical need for mitigating adverse secondary effects from minimally invasive medical procedures, monitoring, and drug delivery devices.

Learn More

Upcoming Events

2024 Innovation Awards Ceremony – March 13, 2024

This event promises to be a remarkable celebration of the astounding achievements of our dedicated faculty and researchers as they continue to make profound contributions to society through their groundbreaking inventions.
MORE DETAILS FORTHCOMING